Protica Bio Ltd.

www.protica.bio

Formerly Protix Bio

High-Tech Company

Graduated from: VLX Ventures

TECH VERTICALS

Artificial Intelligence, BioConvergence, Biotechnology, Computational Biology, Diagnostics, Life Sciences, Machine Learning, MedTech

General Data

Sector	Biomed
Company Stage:	R&D
Established	2022
Number of Employees	5
Reg. Number:	abCDe

DESCRIPTION

At Protica Bio, is is at the forefront of leveraging proteomics and Al to identify predictive biomarkers to immunotherapy and novel drug targets and immune response markers, with the ultimate goal of transforming cancer treatment paradigms. The company's proteomics pipeline enables high coverage and low-abundance proteins detection.
Protica is dedicated to understanding each patient's distinct reaction to cancer treatment, addressing a critical challenge in current clinical oncology – treatment resistance. With an experienced team of professionals and bolstered by a clinical trial, Protica stands at the forefront of advancing precision diagnostics while expanding its clinical research and capabilities.

TECHNOLOGY

Protica Bio is combining proteomics and machine learning to improve immunotherapy-based clinical decisions and new drug discoveries to improve diagnostic prediction and future treatment.

Products and Phases

Product	Phase
N/A	Phase I
An operator of a bio-convergence platform, intended to provide efficient ways for immunotherapy treatments.

	TARGET MARKETS
	Healthcare industry, Health Insurance companies, Pharma companies.

	BUSINESS MODEL
	B2B

CONTACT INFO

Expand / Collapse All

Main Address: Jerusalem, Israel

Address	1 Prof. Rakah St., High-Tech Village, Givat Ram Campus
POB	39158
City	Jerusalem
Country	Israel
Zip	9190401

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Dr. Olga Nissan	CEO & Founder	EcoPhage (Technology Manager)
Prof. Tamar Geiger	CSO
Ms. Dana Cohen	Co-Founder

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Executive Chairman	Chief Business Officer, VLX Ventures
abC Defghij	Board Member	Co-Founder, Protica Bio

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Seed - Extended

Jul. 03, 2022

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe	R&D Grant
abC Defghij	Incubator	abCDe

Seed

Jan. 01, 2022

Seed

abCDe

Last Updated:	abCDe
IVC Number:	abCDe